title: Synergistic effect of cAMP and palmitate in promoting altered mitochondrial function and cell death in HepG2 cells.
abstract: Saturated free fatty acids (FFAs), e.g. palmitate, have long been shown to induce toxicity and cell death in various types of cells. In this study, we demonstrate that cAMP synergistically amplifies the effect of palmitate on the induction of cell death in human hepatocellular carcinoma cell line, HepG2 cells. Elevation of cAMP level in palmitate-treated cells led to enhanced mitochondrial fragmentation, mitochondrial reactive oxygen species (ROS) generation and mitochondrial biogenesis. Mitochondrial fragmentation precedes mitochondrial ROS generation and mitochondrial biogenesis, and may contribute to mitochondrial ROS overproduction and subsequent mitochondrial biogenesis. Fragmentation of mitochondria also facilitated the release of cytotoxic mitochondrial proteins, such as Smac, from the mitochondria and subsequent activation of caspases. However, cell death induced by palmitate and cAMP was caspase-independent and mainly necrotic.
authors.affiliation: Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI 48824, USA.
authors.forename: Linxia
authors.initials: L
authors.lastname: Zhang
authors.forename: Linsey C
authors.initials: LC
authors.lastname: Seitz
authors.forename: Amy M
authors.initials: AM
authors.lastname: Abramczyk
authors.forename: Christina
authors.initials: C
authors.lastname: Chan
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000378:metabolism; D000818:Animals; D051017:Apoptosis Regulatory Proteins; D020169:Caspases / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects* / Q000502:physiology; D005576:Colforsin / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005227:Fatty Acids / Q000378:metabolism; D056945:Hep G2 Cells / Q000187:drug effects / Q000502:physiology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism* / Q000648:ultrastructure; D024101:Mitochondrial Proteins / Q000378:metabolism; D010084:Oxidation-Reduction; D010168:Palmitates / Q000378:metabolism / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
chemical_list: D051017:Apoptosis Regulatory Proteins; C412403:DIABLO protein, human; D005227:Fatty Acids; D047908:Intracellular Signaling Peptides and Proteins; D024101:Mitochondrial Proteins; D010168:Palmitates; D010726:Phosphodiesterase Inhibitors; D017382:Reactive Oxygen Species; D014280:Triglycerides; D005576:Colforsin; D000242:Cyclic AMP; D020169:Caspases; D015056:1-Methyl-3-isobutylxanthine